
Berkeley Catalyst Fund (BCF)
Description
Berkeley Catalyst Fund (BCF) is an early-stage venture capital firm deeply rooted in the innovation ecosystem of the University of California, Berkeley. Established with a mission to commercialize groundbreaking research and technologies emerging from UC Berkeley and the broader Bay Area, BCF serves as a crucial bridge between academic discovery and market-ready solutions. The firm leverages its unique affiliation with one of the world's leading public universities, providing portfolio companies with unparalleled access to a vast network of faculty, alumni, and scientific expertise, alongside strategic capital.
BCF primarily targets seed and Series A stage companies that are developing disruptive technologies in sectors such as deep tech, life sciences, advanced materials, cleantech, and artificial intelligence. They seek ventures that possess strong intellectual property, a clear path to commercialization, and a passionate founding team. The fund's investment thesis centers on identifying and nurturing companies that can address significant market needs with science-backed innovations, often stemming directly from university labs. Their hands-on approach extends beyond capital, offering strategic guidance, operational support, and connections to industry leaders.
The firm typically deploys initial investments ranging from $250,000 to $1,000,000, demonstrating their commitment to supporting nascent ventures at critical junctures. With a reported fund size for BCF II around $50 million, they possess the capacity for follow-on investments to support portfolio companies through subsequent growth stages. BCF's strategy emphasizes long-term partnerships, aiming to help founders navigate the complexities of scaling deep technology companies from concept to market leadership. Their focus on the Berkeley ecosystem ensures a pipeline of high-potential, research-driven startups poised for significant impact.
Investor Profile
Berkeley Catalyst Fund (BCF) has backed more than 37 startups, with 1 new investments in the last 12 months alone. The firm has led 9 rounds, about 24% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Ireland.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $250K – $1M.
Stage Focus
- Series A (32%)
- Seed (27%)
- Series B (19%)
- Series Unknown (11%)
- Series C (5%)
- Pre Seed (3%)
- Debt Financing (3%)
Country Focus
- United States (97%)
- Ireland (3%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Life Science
- Medical Device
- Manufacturing
- Therapeutics
- Genetics
- Information Technology
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Berkeley Catalyst Fund (BCF) frequently co-invest with?
Which angels does Berkeley Catalyst Fund (BCF) often collaborate with?
What are some of recent deals done by Berkeley Catalyst Fund (BCF)?
Find More Investors Like Berkeley Catalyst Fund (BCF)
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








